Literature DB >> 29740945

Alexander disease: an astrocytopathy that produces a leukodystrophy.

Alexander Sosunov1, Markel Olabarria2, James E Goldman2.   

Abstract

Alexander Disease (AxD) is a degenerative disorder caused by mutations in the GFAP gene, which encodes the major intermediate filament of astrocytes. As other cells in the CNS do not express GFAP, AxD is a primary astrocyte disease. Astrocytes acquire a large number of pathological features, including changes in morphology, the loss or diminution of a number of critical astrocyte functions and the activation of cell stress and inflammatory pathways. AxD is also characterized by white matter degeneration, a pathology that has led it to be included in the "leukodystrophies." Furthermore, variable degrees of neuronal loss take place. Thus, the astrocyte pathology triggers alterations in other cell types. Here, we will review the neuropathology of AxD and discuss how a disease of astrocytes can lead to severe pathologies in non-astrocytic cells. Our knowledge of the pathophysiology of AxD will also lead to a better understanding of how astrocytes interact with other CNS cells and how astrocytes in the gliosis that accompanies many neurological disorders can damage the function and survival of other cells.
© 2018 International Society of Neuropathology.

Entities:  

Keywords:  Alexander disease; GFAP; astrocytes; leukodystrophy

Mesh:

Year:  2018        PMID: 29740945     DOI: 10.1111/bpa.12601

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  22 in total

Review 1.  Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.

Authors:  April L Risinger; Lin Du
Journal:  Nat Prod Rep       Date:  2019-11-25       Impact factor: 13.423

2.  Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.

Authors:  Michael R Heaven; Landon Wilson; Stephen Barnes; Michael Brenner
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

Review 3.  The Role of TDP-43 in Neurodegenerative Disease.

Authors:  Yan-Zhe Liao; Jing Ma; Jie-Zhi Dou
Journal:  Mol Neurobiol       Date:  2022-05-02       Impact factor: 5.590

Review 4.  Alexander disease: models, mechanisms, and medicine.

Authors:  Tracy L Hagemann
Journal:  Curr Opin Neurobiol       Date:  2021-11-23       Impact factor: 6.627

5.  Identification of association fibers using ex vivo diffusion tractography in Alexander disease brains.

Authors:  Tadashi Shiohama; Natalie Stewart; Masahito Nangaku; Andre J W van der Kouwe; Emi Takahashi
Journal:  J Neuroimaging       Date:  2022-08-19       Impact factor: 2.324

6.  Pathology of the neurovascular unit in leukodystrophies.

Authors:  Parand Zarekiani; Marjolein Breur; Nicole I Wolf; Helga E de Vries; Marjo S van der Knaap; Marianna Bugiani
Journal:  Acta Neuropathol Commun       Date:  2021-06-03       Impact factor: 7.801

Review 7.  Heterogeneity of white matter astrocytes in the human brain.

Authors:  Marianna Bugiani; Bonnie C Plug; Jodie H K Man; Marjolein Breur; Marjo S van der Knaap
Journal:  Acta Neuropathol       Date:  2021-12-08       Impact factor: 17.088

Review 8.  Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System.

Authors:  Erik Nutma; Démi van Gent; Sandra Amor; Laura A N Peferoen
Journal:  Cells       Date:  2020-03-03       Impact factor: 6.600

9.  A Case Report of Adult-Onset Alexander Disease with a Tumor-Like Lesion in the Lateral Ventricle.

Authors:  Tongjia Cai; Sisi Jing; Ying Li; Jianjun Wu
Journal:  Case Rep Neurol       Date:  2021-06-11

10.  A Synergistic Effect of Reactive Oxygen and Reactive Nitrogen Species in Plasma Activated Liquid Media Triggers Astrocyte Wound Healing.

Authors:  Eloisa Sardella; Maria Grazia Mola; Roberto Gristina; Monica Piccione; Valeria Veronico; Manuela De Bellis; Antonio Cibelli; Maura Buttiglione; Vincenza Armenise; Pietro Favia; Grazia Paola Nicchia
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.